Personalized Medicine: A New Normal for Therapeutic Success

被引:4
作者
Sarvan, M. S. [1 ]
Nori, Lakshmi Prasanthi [2 ]
机构
[1] Vignan Coll Pharm, Dept Pharm, Vadlamudi, India
[2] Vignans Fdn Sci Technol & Res Deemed Univ, Dept Pharmaceut Sci, Guntur 522213, Andhra Pradesh, India
关键词
Personalized medicine; precision medicine; genomics; biomarkers; epigenetics; DNA METHYLATION BIOMARKERS; DISEASES; PHARMACOGENOMICS; ASSOCIATION; EPIGENETICS; VALIDATION; METABOLISM; EXPRESSION;
D O I
10.36468/pharmaceutical-sciences.790
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this article is to provide a framework for understanding the principles of personalized and precision medicine. Since the advent of the human genome project in 1990, the approach to precision and accurate medicine has been changed. This turns the practice from the "one size fits all" paradigm into one that tailors patient identification, diagnosis and treatment. Personalized medicine has been a disputed vision of the future for two decades. A humanized approach to personalized medicine will offer the possibility of leveraging the physiology of processes and its application of personalized, predictive, participatory, precision and preventive P5 medicine. The predictive variables for the progression of a disease should be investigated within communities to determine preventive measures for at risk people and healthcare can be customized and participative. Accurate diagnosis, surveillance and treatment of diseases includes developments in the identification of biomarkers, the subsequent development of reliable signatures that suit complex disease states, as well as medical approaches that can be continually modified and modulated for dosage and medication selection. This review illustrates significant breakthroughs in the advancement of emerging technology and obstacles of personalized and precise medicine. It will create groundbreaking capabilities in the realization of fully individualized patient care.
引用
收藏
页码:416 / 429
页数:14
相关论文
共 57 条
  • [21] Epigenetic Changes in Gene Expression for Drug-Metabolizing Enzymes and Transporters
    Kim, In-Wha
    Han, Nayoung
    Burckart, Gilbert J.
    Oh, Jung Mi
    [J]. PHARMACOTHERAPY, 2014, 34 (02): : 140 - 150
  • [22] Kordou Z, 2020, TRANSL APPL GENOM, P259, DOI 10.1016/B978-0-12-813695-9.00014-5
  • [23] Kronfol MM, 2017, EXPERT REV PRECIS ME, V2, P33, DOI 10.1080/23808993.2017.1284557
  • [24] MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges
    Lan, Huiyin
    Lu, Haiqi
    Wang, Xian
    Jin, Hongchuan
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [25] The Impact of Pharmacogenomics Research on Drug Development
    Liou, Shyh-Yuh
    Stringer, Fran
    Hirayama, Masashi
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2012, 27 (01) : 2 - 8
  • [26] Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears
    Lithwick-Yanai, Gila
    Dromi, Nir
    Shtabsky, Alexander
    Morgenstern, Sara
    Strenov, Yulia
    Feinmesser, Meora
    Kravtsov, Vladimir
    Leon, Marino E.
    Hajduch, Marian
    Ali, Syed Z.
    VandenBussche, Christopher J.
    Zhang, Xinmin
    Leider-Trejo, Leonor
    Zubkov, Asia
    Vorobyov, Sergey
    Kushnir, Michal
    Goren, Yaron
    Tabak, Sarit
    Kadosh, Etti
    Benjamin, Hila
    Schnitzer-Perlman, Temima
    Marmor, Hagai
    Motin, Maria
    Lebanony, Danit
    Kredo-Russo, Sharon
    Mitchell, Heather
    Noller, Melissa
    Smith, Alexis
    Dattner, Olivia
    Ashkenazi, Karin
    Sanden, Mats
    Berlin, Kenneth A.
    Bar, Dganit
    Meiri, Eti
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2017, 70 (06) : 500 - 507
  • [27] Lonie I M, 1978, Hist Sci, V16, P42
  • [28] Lonie I M, 1978, Hist Sci, V16, P77
  • [29] HSD11B2, RUNX3, and LINE-1 Methylation in Placental DNA of Hypertensive Disorders of Pregnancy Patients
    Majchrzak-Celinska, Aleksandra
    Kosicka, Katarzyna
    Paczkowska, Julia
    Glowka, Franciszek K.
    Breborowicz, Grzegorz H.
    Krzyscin, Mariola
    Siemiatkowska, Anna
    Szaumkessel, Marcin
    Baer-Dubowska, Wanda
    [J]. REPRODUCTIVE SCIENCES, 2017, 24 (11) : 1520 - 1531
  • [30] Detection of MGMT, RASSF1A, p15INK4B, and p14ARF promoter methylation in circulating tumor-derived DNA of central nervous system cancer patients
    Majchrzak-Celinska, Aleksandra
    Paluszczak, Jaroslaw
    Kleszcz, Robert
    Magiera, Marta
    Barciszewska, Anna-Maria
    Nowak, Stanislaw
    Baer-Dubowska, Wanda
    [J]. JOURNAL OF APPLIED GENETICS, 2013, 54 (03) : 335 - 344